LXY6090 T27866
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LXY6090 is a HIF-1 inhibitor. LXY6090 inhibited the activity of HIF-1 and downregulated the protein level of HIF-1_ in breast cancer cells. LXY6090 showed in vivo anticancer efficacy by decreasing the HIF-1_ expression in nude mice bearing MX-1 tumor xeno
CAS nr:
T27866
Purity:
98%
Molecular Weight:
580,68
SMILES:
O=C(COC1=CC=C([C@@H]2C[C@H](C3=CC=C(OCC(NC4=CC=CC=C4)=O)C(OC)=C3)CC2)C=C1OC)NC5=CC=CC=C5
Formula:
C35H36N2O6
Pathway:
Target:
